13F-HR filed by Kalehua Capital Management LLC
Kalehua Capital Management LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 19 holding rows worth $101,099,761.
- Accession
- 0002106181-26-000003
- Filer
- CIK 2106181
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 19 entries on the cover page, a total value of $101,099,761 stated on the cover page (in dollars after the unit check, H1), rows summing to $101,099,761 with VALUE read as dollars as filed, 13F file number 028-26381. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 230,787 | $26,563,584 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 3,722,840 | $14,891,360 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 197,072 | $8,107,542 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 901,457 | $7,626,326 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 819,692 | $5,655,875 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 198,772 | $5,515,923 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 194,544 | $5,423,887 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 118,524 | $3,592,462 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 1,750,000 | $3,587,500 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,546,129 | $3,488,197 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 393,701 | $2,980,317 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 175,734 | $2,316,174 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 267,059 | $2,184,543 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 235,779 | $1,959,323 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 74,465 | $1,957,685 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 385,178 | $1,886,241 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 2,000,000 | $1,423,000 | dollars as filed | |
| KALARIS THERAPEUTICS INC | 482929106 | COM | 139,901 | $1,180,764 | dollars as filed | |
| DIAMEDICA THERAPEUTICS INC | 25253X207 | COMMON STOCK | 95,359 | $759,058 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002106181-26-000003 | this filing | 2026-02-13 | acceptance time not in the bulk data set |